Targeting the Tie-2 Receptor With Faricimab in Central Serous Chorioretinopathy: A Case Series Motivated by a Genetic Finding. Ramo JT, Kim LA, Stryjewski T, Shah PP, et al. Am J Ophthalmol 2025;269:246-254.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ramo JT, Kim LA, Stryjewski T, Shah PP, et al. Targeting the Tie-2 Receptor With Faricimab in Central Serous Chorioretinopathy: A Case Series Motivated by a Genetic Finding. Am J Ophthalmol 2025;269:246-254.
PMID: 39233019